BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 11917313)

  • 1. Treatments for common superficial fungal infections.
    Aly R; Forney R; Bayles C
    Dermatol Nurs; 2001 Apr; 13(2):91-4, 98-9; quiz 100-1. PubMed ID: 11917313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis.
    Del Rosso JQ; Kircik LH
    J Drugs Dermatol; 2013 Nov; 12(11 Suppl):s165-71. PubMed ID: 24196340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New antifungal agents.
    Lesher JL
    Dermatol Clin; 1992 Oct; 10(4):799-805. PubMed ID: 1327600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New antifungal agents in the treatment of superficial dermatomycoses].
    Degreef H
    Ann Dermatol Venereol; 1993; 120(1):21-31. PubMed ID: 8393313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fungal infections of the skin: infection process and antimycotic therapy.
    Borgers M; Degreef H; Cauwenbergh G
    Curr Drug Targets; 2005 Dec; 6(8):849-62. PubMed ID: 16375669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terbinafine. A pharmacoeconomic evaluation of its use in superficial fungal infections.
    Davis R; Balfour JA
    Pharmacoeconomics; 1995 Sep; 8(3):253-69. PubMed ID: 10155621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of topical therapy for common superficial fungal infections and the role of new topical agents.
    Brennan B; Leyden JJ
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S3-8. PubMed ID: 9039198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of terbinafine in experimental fungal infections of laboratory animals.
    Petranyi G; Meingassner JG; Mieth H
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1558-61. PubMed ID: 3435103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review of topical treatments for fungal infections of the skin and nails of the feet.
    Hart R; Bell-Syer SE; Crawford F; Torgerson DJ; Young P; Russell I
    BMJ; 1999 Jul; 319(7202):79-82. PubMed ID: 10398626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New and prospective developments in antifungal drugs.
    Cauwenbergh G
    Acta Derm Venereol Suppl (Stockh); 1986; 121():147-53. PubMed ID: 3012922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on topical therapy for superficial fungal infections: focus on butenafine.
    Odom RB
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S1-2. PubMed ID: 9039197
    [No Abstract]   [Full Text] [Related]  

  • 12. Topical therapy for fungal infections.
    Kyle AA; Dahl MV
    Am J Clin Dermatol; 2004; 5(6):443-51. PubMed ID: 15663341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of common superficial fungal infections.
    Huang DB; Ostrosky-Zeichner L; Wu JJ; Pang KR; Tyring SK
    Dermatol Ther; 2004; 17(6):517-22. PubMed ID: 15571501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azole tolerance test: a bedside observation to enhance physical diagnosis of superficial fungal infection.
    Schneiderman H; Kristof L
    Conn Med; 2012 Feb; 76(2):124. PubMed ID: 22670369
    [No Abstract]   [Full Text] [Related]  

  • 15. Superficial fungal infections of the skin. Diagnosis and current treatment recommendations.
    Rezabek GH; Friedman AD
    Drugs; 1992 May; 43(5):674-82. PubMed ID: 1379146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycological Considerations in the Topical Treatment of Superficial Fungal Infections.
    Rosen T
    J Drugs Dermatol; 2016 Feb; 15(2 Suppl):s49-55. PubMed ID: 26885799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Topical Therapeutic Options in the Management of Superficial Fungal Infections.
    Zeichner JA
    J Drugs Dermatol; 2015 Oct; 14(10 Suppl):s35-41. PubMed ID: 26461833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatophyte infections.
    Hainer BL
    Am Fam Physician; 2003 Jan; 67(1):101-8. PubMed ID: 12537173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual dermatomycoses caused by Nannizzia nana: the geophilic origin of human infections.
    Gnat S; Łagowski D; Nowakiewicz A; Dyląg M
    Infection; 2020 Jun; 48(3):429-434. PubMed ID: 32232786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of systemic antimycotics in dermatotherapy.
    Niewerth M; Korting HC
    Eur J Dermatol; 2000 Mar; 10(2):155-60. PubMed ID: 10694319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.